Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.

Toriola AT, Luo S, Thomas TS, Drake BF, Chang SH, Sanfilippo KM, Carson KR.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):169-175. doi: 10.1158/1055-9965.EPI-19-0781. Epub 2019 Nov 4.

PMID:
31685560
2.

Diagnostic Performance of Prostate Multiparametric Magnetic Resonance Imaging in African-American Men.

Henning GM, Vetter JM, Drake BF, Ippolito JE, Shetty AS, Andriole GL, Kim EH.

Urology. 2019 Dec;134:181-185. doi: 10.1016/j.urology.2019.08.007. Epub 2019 Aug 13.

PMID:
31419432
3.

An Evaluation of Follow-Up Activities of Participants From an Urban Prostate Cancer Screening Event.

Drake BF, Lewis-Thames MW, Brown A, Rancilio D, Hicks V.

Am J Mens Health. 2019 Mar-Apr;13(2):1557988319844353. doi: 10.1177/1557988319844353.

4.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6.

PMID:
30622367
5.

The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Farnan L, Drake BF, Olshan AF, Bensen JT.

Cancer Causes Control. 2018 Nov;29(11):1143-1150. doi: 10.1007/s10552-018-1087-z. Epub 2018 Sep 28.

6.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z.

Nat Commun. 2018 Jun 11;9(1):2256. doi: 10.1038/s41467-018-04109-8.

7.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11. Erratum in: Nat Genet. 2019 Feb;51(2):363.

8.

The burden of prostate cancer in Trinidad and Tobago: one of the highest mortality rates in the world.

Warner WA, Lee TY, Fang F, Llanos AAM, Bajracharya S, Sundaram V, Badal K, Sookdeo VD, Roach V, Lamont-Greene M, Ragin C, Slovacek S, Ramsoobhag K, Brown J, Rebbeck TR, Maharaj R, Drake BF.

Cancer Causes Control. 2018 Jul;29(7):685-697. doi: 10.1007/s10552-018-1038-8. Epub 2018 May 17.

9.

Predictors of Follow-Up Visits Post Radical Prostatectomy.

Khan S, Hicks V, Rancilio D, Langston M, Richardson K, Drake BF.

Am J Mens Health. 2018 Jul;12(4):760-765. doi: 10.1177/1557988318762633. Epub 2018 Mar 14.

10.

EVALUATING COMMUNITY ENGAGEMENT IN RESEARCH: QUANTITATIVE MEASURE DEVELOPMENT.

Goodman MS, Sanders Thompson VL, Johnson CA, Gennarelli R, Drake BF, Bajwa P, Witherspoon M, Bowen D.

J Community Psychol. 2017 Jan;45(1):17-32. doi: 10.1002/jcop.21828. Epub 2016 Dec 13.

11.

The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence.

Khan S, Hicks V, Colditz GA, Kibel AS, Drake BF.

Int J Cancer. 2018 May 15;142(10):2011-2018. doi: 10.1002/ijc.31229. Epub 2018 Jan 10.

12.

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Sellers TA, Yamoah K, Murphy AB, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Stern MC, Jarai ZK, Govindasami K, Chokkalingam AP, Hsing AW, Goodman PJ, Hoffmann T, Drake BF, Hu JJ, Clark PE, Van Den Eeden SK, Blanchet P, Fowke JH, Casey G, Hennis AJM, Han Y, Lubwama A, Thompson IM Jr, Leach R, Easton DF, Schumacher F, Van den Berg DJ, Gundell SM, Stram A, Wan P, Xia L, Pooler LC, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Srivastava S, Eeles RA, Carpten J, Kibel AS, Multigner L, Parent ME, Menegaux F, Cancel-Tassin G, Klein EA, Brureau L, Stram DO, Watya S, Chanock SJ, Witte JS, Blot WJ, Henderson BE, Haiman CA; PRACTICAL/ELLIPSE Consortium.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx084.

13.

Incidence of Cancer in Spinal Deformity Patients Receiving High-Dose (≥40 mg) Bone Morphogenetic Protein (rhBMP-2).

Baldus C, Kelly MP, Yanik EL, Drake BF, Ahmad A, Mesfin A, Bridwell KH.

Spine (Phila Pa 1976). 2017 Dec 1;42(23):1785-1791. doi: 10.1097/BRS.0000000000002232.

PMID:
28498289
14.

African American prostate cancer survivorship: Exploring the role of social support in quality of life after radical prostatectomy.

Imm KR, Williams F, Housten AJ, Colditz GA, Drake BF, Gilbert KL, Yang L.

J Psychosoc Oncol. 2017 Jul-Aug;35(4):409-423. doi: 10.1080/07347332.2017.1294641. Epub 2017 Apr 11.

15.

Physician role in physical activity for African-American males undergoing radical prostatectomy for prostate cancer.

Williams F, Imm KR, Colditz GA, Housten AJ, Yang L, Gilbert KL, Drake BF.

Support Care Cancer. 2017 Apr;25(4):1151-1158. doi: 10.1007/s00520-016-3505-7. Epub 2016 Dec 21.

16.

Obesity and Other Cancers.

Yang L, Drake BF, Colditz GA.

J Clin Oncol. 2016 Dec 10;34(35):4231-4237. Epub 2016 Nov 7. Review.

PMID:
27903157
17.

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.

Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS.

Cancer Prev Res (Phila). 2016 Dec;9(12):933-941. Epub 2016 Sep 20.

18.

Secondary consent to biospecimen use in a prostate cancer biorepository.

Drake BF, Brown K, McGowan LD, Haslag-Minoff J, Kaphingst K.

BMC Res Notes. 2016 Jul 18;9:346. doi: 10.1186/s13104-016-2159-3.

19.

Development of Plain Language Supplemental Materials for the Biobank Informed Consent Process.

Drake BF, Brown KM, Gehlert S, Wolf LE, Seo J, Perkins H, Goodman MS, Kaphingst KA.

J Cancer Educ. 2017 Dec;32(4):836-844. doi: 10.1007/s13187-016-1029-y.

20.

Reduction of Parathyroid Hormone with Vitamin D Supplementation in Blacks: A Randomized Controlled Trial.

Chandler PD, Agboola F, Ng K, Scott JB, Drake BF, Bennett GG, Chan AT, Hollis BW, Emmons KM, Fuchs CS, Giovannucci EL.

BMC Nutr. 2015;1. pii: 26. Epub 2015 Dec 17.

21.

Barriers and Strategies to Participation in Tissue Research Among African-American Men.

Drake BF, Boyd D, Carter K, Gehlert S, Thompson VS.

J Cancer Educ. 2017 Mar;32(1):51-58. doi: 10.1007/s13187-015-0905-1.

22.

Differences in preferences for models of consent for biobanks between Black and White women.

Brown KM, Drake BF, Gehlert S, Wolf LE, DuBois J, Seo J, Woodward K, Perkins H, Goodman MS, Kaphingst KA.

J Community Genet. 2016 Jan;7(1):41-9. doi: 10.1007/s12687-015-0248-y. Epub 2015 Aug 25.

23.

A Tale of Two Community Networks Program Centers: Operationalizing and Assessing CBPR Principles and Evaluating Partnership Outcomes.

Arroyo-Johnson C, Allen ML, Colditz GA, Hurtado GA, Davey CS, Sanders Thompson VL, Drake BF, Svetaz MV, Rosas-Lee M, Goodman MS.

Prog Community Health Partnersh. 2015;9 Suppl:61-9. doi: 10.1353/cpr.2015.0026.

24.

Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months.

Chandler PD, Giovannucci EL, Scott JB, Bennett GG, Ng K, Chan AT, Hollis BW, Rifai N, Emmons KM, Fuchs CS, Drake BF.

Sci Rep. 2015 Jun 22;5:10411. doi: 10.1038/srep10411.

25.

A Community-Based Partnership to Successfully Implement and Maintain a Breast Health Navigation Program.

Drake BF, Tannan S, Anwuri VV, Jackson S, Sanford M, Tappenden J, Goodman MS, Colditz GA.

J Community Health. 2015 Dec;40(6):1216-23. doi: 10.1007/s10900-015-0051-z.

26.

Impact of vitamin D supplementation on adiposity in African-Americans.

Chandler PD, Scott JB, Drake BF, Ng K, Chan AT, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Bennett GG.

Nutr Diabetes. 2015 Jun 15;5:e164. doi: 10.1038/nutd.2015.14. No abstract available.

27.

Mammograms on-the-go-predictors of repeat visits to mobile mammography vans in St Louis, Missouri, USA: a case-control study.

Drake BF, Abadin SS, Lyons S, Chang SH, Steward LT, Kraenzle S, Goodman MS.

BMJ Open. 2015 Mar 20;5(3):e006960. doi: 10.1136/bmjopen-2014-006960.

28.

Impact of vitamin D supplementation on adiposity in African-Americans.

Chandler PD, Scott JB, Drake BF, Ng K, Chan AT, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Bennett GG.

Nutr Diabetes. 2015 Jan 19;5:e147. doi: 10.1038/nutd.2014.44. Erratum in: Nutr Diabetes. 2015 Jun 15;5:e164.

29.

Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial.

Chandler PD, Giovannucci EL, Scott JB, Bennett GG, Ng K, Chan AT, Hollis BW, Emmons KM, Fuchs CS, Drake BF.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1944-7. doi: 10.1158/1055-9965.EPI-14-0522. Epub 2014 Jun 28.

30.

Perceived barriers to mammography among underserved women in a Breast Health Center Outreach Program.

Fayanju OM, Kraenzle S, Drake BF, Oka M, Goodman MS.

Am J Surg. 2014 Sep;208(3):425-34. doi: 10.1016/j.amjsurg.2014.03.005. Epub 2014 May 4.

31.

Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.

Chandler PD, Scott JB, Drake BF, Ng K, Forman JP, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS.

Am J Med. 2014 Aug;127(8):772-8. doi: 10.1016/j.amjmed.2014.02.044. Epub 2014 Mar 20.

32.

Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial.

Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, Bennett GG, Giovannucci EL, Gonzalez-Suarez E, Meyerhardt JA, Emmons KM, Fuchs CS.

Am J Clin Nutr. 2014 Mar;99(3):587-98. doi: 10.3945/ajcn.113.067777. Epub 2013 Dec 24.

33.

Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Chandler PD, Scott JB, Drake BF, Ng K, Manson JE, Rifai N, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS.

Cancer Prev Res (Phila). 2014 Feb;7(2):218-25. doi: 10.1158/1940-6207.CAPR-13-0338-T. Epub 2013 Dec 10.

34.

Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF.

J Natl Cancer Inst. 2013 Sep 18;105(18):1344-54. doi: 10.1093/jnci/djt223. Epub 2013 Aug 29. Review.

35.

Comparing strategies to assess multiple behavior change in behavioral intervention studies.

Drake BF, Quintiliani LM, Sapp AL, Li Y, Harley AE, Emmons KM, Sorensen G.

Transl Behav Med. 2013 Mar 1;3(1):114-121. Epub 2013 Jan 15.

36.

Effect of vitamin D supplementation on blood pressure in blacks.

Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Chan AT.

Hypertension. 2013 Apr;61(4):779-85. doi: 10.1161/HYPERTENSIONAHA.111.00659.

37.

"Don't know" responses to risk perception measures: implications for underserved populations.

Waters EA, Hay JL, Orom H, Kiviniemi MT, Drake BF.

Med Decis Making. 2013 Feb;33(2):271-81. doi: 10.1177/0272989X12464435.

38.

Breast cancer presentation in an urban health care Safety Net system.

Fayanju OM, Jeffe DB, Tappenden JR, Beers CE, Drake BF, Gao F, Margenthaler JA.

Mo Med. 2012 Sep-Oct;109(5):405-11.

39.

Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.

Wagner SE, Drake BF, Elder K, Hébert JR.

Cancer Causes Control. 2011 Nov;22(11):1597-606. doi: 10.1007/s10552-011-9836-2. Epub 2011 Aug 30.

40.

Successful subject recruitment for a prostate cancer behavioral intervention trial.

Heiney SP, Arp Adams S, Drake BF, Bryant LH, Bridges L, Hebert JR.

Clin Trials. 2010 Aug;7(4):411-7. doi: 10.1177/1740774510373491. Epub 2010 Jun 22.

41.
42.

Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey.

Lathan CS, Okechukwu C, Drake BF, Bennett GG.

Cancer. 2010 Apr 15;116(8):1981-6. doi: 10.1002/cncr.24923.

43.

Assessing cancer prevention studies--a matter of time.

Drake BF, Colditz GA.

JAMA. 2009 Nov 18;302(19):2152-3. doi: 10.1001/jama.2009.1691. No abstract available.

44.

A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men.

Allen JD, Mohllajee AP, Shelton RC, Drake BF, Mars DR.

Am J Mens Health. 2009 Dec;3(4):340-51. doi: 10.1177/1557988308325460. Epub 2008 Oct 20.

45.

Racial differences in prostate cancer screening by family history.

Drake BF, Lathan CS, Okechukwu CA, Bennett GG.

Ann Epidemiol. 2008 Jul;18(7):579-83. doi: 10.1016/j.annepidem.2008.02.004. Epub 2008 May 16.

46.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238

Supplemental Content

Loading ...
Support Center